heptaplatin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The anti-cancer Nano drugs Cisplatin, Carboplatin, Nedaplatin, Oxaliplatin, Heptaplatin and Lobaplatin were characterized by… (More)
  • figure 1
Is this relevant?
2014
2014
PURPOSE Lobaplatin, heptaplatin, and dicycloplatin are three new platinum drugs. The aim of this study is to investigate the… (More)
Is this relevant?
2011
2011
A novel water-soluble heptaplatin analogue, cis-[(4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3-dioxolane](3-hydroxy-1,1… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Since its approval in 1979 cisplatin has become an important component in chemotherapy regimes for the treatment of ovarian… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2010
2010
The present study was conducted to test the possible teratogenic and toxic effects of anti-cancer drug heptaplatin (SKI 2053) on… (More)
Is this relevant?
2009
2009
PURPOSE Heptaplatin (Sunpla) is a cisplatin derivative. A phase IIb trial using heptaplatin resulted in a 34% response rate with… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2006
2006
Heptaplatin (HTP), a newly developed platinum analog, has been approved for the treatment of gastric cancers in South Korea. In… (More)
Is this relevant?
2004
2004
Heptaplatin is a new platinum derivative with anticancer activity against various cancer cell lines, including cisplatin… (More)
  • table 1
Is this relevant?
2004
2004
Heptaplatin is a recently developed platinum derivative. This agent has been reported to have a response rate of 17% as a single… (More)
  • table 2
  • table 1
  • figure 1
  • table 3
Is this relevant?
2002
2002
Abstract Purpose. Heptaplatin is a newly developed platinum derivative which has been reported to be less toxic than cisplatin… (More)
  • table 2
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?